Structure and Function of G Protein Coupled Receptors

The G protein coupled receptors (GPC-Rs) comprise a large superfamily of genes encoding numerous receptors which all show common structural features, e.g., seven putative membrane spanning domains. Their biological functions are extremely diverse, ranging from vision and olfaction to neuronal and endocrine signaling. The GPC-Rs couple via multiple G proteins to a growing number of recognized second messenger pathway, e.g., cAMP and phosphatidyl inositol turnover. This review summarizes our current knowledge of the molecular mechanisms by which the GPC-Rs activate second messenger systems, and it addresses their regulation and structure.

[1]  C. Strader,et al.  Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.

[2]  P. Casey,et al.  G protein involvement in receptor-effector coupling. , 1988, The Journal of biological chemistry.

[3]  P. Hargrave,et al.  Molecular biology of the visual pigments , 1986, Vision Research.

[4]  G. Stiles,et al.  The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover. , 1988, Molecular pharmacology.

[5]  A. Tarver,et al.  Inositol 1,4,5-trisphosphate and inositol 1,2-cyclic 4,5-trisphosphate are minor components of total mass of inositol trisphosphate in thrombin-stimulated platelets. Rapid formation of inositol 1,3,4-trisphosphate. , 1987, The Journal of biological chemistry.

[6]  H. Breer,et al.  Rapid kinetics of second messenger formation in olfactory transduction , 1990, Nature.

[7]  L. Limbird.  The alpha-2 Adrenergic Receptors , 1988, The Receptors.

[8]  C. M. Davenport,et al.  Molecular genetics of human blue cone monochromacy. , 1989, Science.

[9]  J. Deisenhofer,et al.  The Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas viridis , 1989, Science.

[10]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[11]  J. Nathans,et al.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin , 1983, Cell.

[12]  A. S. Bogachuk,et al.  Two adjacent cysteine residues in the C‐terminal cytoplasmic fragment of bovine rhodopsin are palmitylated , 1988, FEBS letters.

[13]  David E. Clapham,et al.  Roles of G protein subunits in transmembrane signalling , 1988, Nature.

[14]  A. Ashkenazi,et al.  An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. , 1987, Science.

[15]  N. Nathanson,et al.  Deletion analysis of the mouse m1 muscarinic acetylcholine receptor: effects on phosphoinositide metabolism and down-regulation. , 1989, Biochemistry.

[16]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[17]  M. Parmentier,et al.  Molecular cloning of the thyrotropin receptor. , 1989, Science.

[18]  Ira Herskowitz,et al.  A regulatory hierarchy for cell specialization in yeast , 1989, Nature.

[19]  W. Sadee,et al.  Internalization of the Hm1 muscarinic cholinergic receptor involves the third cytoplasmic loop , 1990, FEBS letters.

[20]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[21]  J. Marvaldi,et al.  Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29). , 1986, European journal of biochemistry.

[22]  J. Nathans,et al.  Molecular genetics of inherited variation in human color vision. , 1986, Science.

[23]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[24]  E. Ross,et al.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). , 1988, The Journal of biological chemistry.

[25]  H. Bourne.  Who carries what message? , 1989, Nature.

[26]  M. Caron,et al.  Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites. , 1989, Molecular pharmacology.

[27]  Jonathan A. Cooper,et al.  Binding of GAP to activated PDGF receptors. , 1990, Science.

[28]  P. Devreotes.  Dictyostelium discoideum: a model system for cell-cell interactions in development. , 1989, Science.

[29]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[30]  K. Meier,et al.  Activation of protein kinase C induces rapid internalization and subsequent degradation of muscarinic acetylcholine receptors in neuroblastoma cells. , 1986, The Journal of biological chemistry.

[31]  M. Caron,et al.  Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor. , 1989, Biochemistry.

[32]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[33]  David W. Yandell,et al.  A point mutation of the rhodopsin gene in one form of retinitis pigmentosa , 1990, Nature.

[34]  G. H. Jacobs,et al.  Analysis of fusion gene and encoded photopigment of colour-blind humans , 1989, Nature.

[35]  D. Klein,et al.  Essential role of calcium influx in the adrenergic regulation of cAMP and cGMP in rat pinealocytes. , 1986, The Journal of biological chemistry.

[36]  M. Caron,et al.  Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. , 1988, The Journal of biological chemistry.

[37]  W. Schafer,et al.  Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation. , 1990, Science.

[38]  E. Neer,et al.  G0 is a major growth cone protein subject to regulation by GAP-43 , 1990, Nature.

[39]  C. Strader,et al.  Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions. , 1990, Molecular Pharmacology.

[40]  R. Lockshin,et al.  Programmed cell death: Dying cells synthesize a co‐ordinated, unique set of proteins in two different episodes of cell death , 1988, FEBS letters.

[41]  J. Venter,et al.  Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation. , 1988, The Journal of biological chemistry.

[42]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[43]  L. Takemoto,et al.  Regulation of retinal transducin by C-terminal peptides of rhodopsin. , 1985, The Biochemical journal.

[44]  B. Barrell,et al.  Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.

[45]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[46]  H. Khorana,et al.  A single amino acid substitution in rhodopsin (lysine 248----leucine) prevents activation of transducin. , 1988, The Journal of biological chemistry.